Acetazolamide
Overview
Acetazolamide is a carbonic anhydrase inhibitor that is used to treat glaucoma, epilepsy, and altitude sickness. It reduces the formation of hydrogen and bicarbonate ions in the body, which decreases fluid pressure in the eyes and brain.
API suppliers (8)
Suppliers of Acetazolamide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 7 of 8 suppliers.
4 of 8 hold a GMP certificate on record in the EU or UK registers
- GLAND PHARMA LTDIndia1 active DMF GMP on record
- Emcure Pharmaceuticals LimitedIndia1 active DMF GMP on record
- CTX LIFE SCIENCES PVT LTDIndia1 active DMF
- ZAKLADY FARMACEUTYCZNE POLPHARMA SA1 active DMF
- IDT AUSTRALIA LTDAustralia1 active DMF
- NAKODA CHEMICALS LTDIndia1 active DMF
- CAMBREX PROFARMACO MILANO SRLItaly GMP on record
- Teva Pharmaceutical Industries Ltd.Israel GMP on record
EU CEP holders (3)
Companies holding a valid EU Certificate of Suitability (CEP) for Acetazolamide, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Acetazolamide? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.